Phoenix Children's Hospital

This study provides Erwinase, a different form of chemotherapy, to children with acute lymphoblastic leukemia (ALL) who have had allergic reactions to the usual L-asparaginase drugs. The goal is to offer a safe treatment option for these patients. Participants must have confirmed…

This study aimed to see if a smartphone app called GoCheckKids could help detect leukocoria (a white glow in the pupil) in children from birth to 10 years old. Leukocoria is an early sign of retinoblastoma, a rare eye cancer. The study was withdrawn before any participants were e…

This study planned to compare two drugs, oxybutynin and tamsulosin, for reducing discomfort from urinary stents in children aged 4 to 18. Families would track pain scores and painkiller use for five days after surgery. However, the study was withdrawn before enrolling any partici…

This study aimed to see if giving breathing medicine through a mask that uses pressure (positive pressure nebulization) works better than a standard mask to keep infants with bronchiolitis out of the hospital. The trial planned to include infants aged 2 to 24 months with moderate…

This study aimed to see if a sedative given as a nose spray (dexmedetomidine) could work as well as standard IV medicine (ketamine) for children needing a broken forearm bone reset. The trial was withdrawn before any participants were enrolled, so no results are available.

This study aimed to see if giving children with asthma a nebulized steroid (budesonide) after an emergency room visit, on top of standard oral steroids, could reduce the chance of another attack within a month. It planned to enroll children aged 2 to 8 who had an asthma flare-up …

This study was designed to create a program for families of children under 2 who came to the emergency room with a head injury not from a car crash. The program would have included a screening, a supportive conversation, and a referral for extra help. However, the study was withd…

This study was designed to see if a device called LifeFlow® could deliver fluids faster and more safely to children with sepsis in the emergency room compared to the usual push/pull method. It planned to include 600 children under 19 years old, but the study was withdrawn before …